Eruptive keratoacanthomas secondary to nivolumab immunotherapy-Reference-Cited by-同舟云学术

Eruptive keratoacanthomas secondary to nivolumab immunotherapy

Published:2018-01-10 Issue:3 Volume:57 Page:e28-e29
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatol

Author:

Bednarek Robert¹,Marks Katherine¹,Lin George²

Affiliation:

1. Department of Dermatology; Geisinger Medical Center; Danville PA USA

2. Department of Pathology; Division of Dermatopathology; Geisinger Medical Center; Danville PA USA

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ijd.13893/fullpdf

Reference6 articles.

1. Managing immune checkpoint-blocking antibody side effects;Postow;Am Soc Clin Oncol Educ Book,2015

2. Eruptive keratoacanthomas associated with pembrolizumab therapy;Freites-Martinez;JAMA Dermatol,2017

3. Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: a single-institution cohort;Hwang;J Am Acad Dermatol,2016

4. Eruptive keratoacanthomas arising in the setting of lichenoid toxicity after PD1 inhibition with nivolumab;Feldstein;J Eur Acad Dermatol Venereol,2017

5. Eruptive keratoacanthoma and squamous cell carcinoma complicating imiquimod therapy: response to oral acitretin;Foxton;Australas J Dermatol,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delayed onset eruptive keratoacanthomas following immune checkpoint inhibitor therapy;International Journal of Dermatology;2024-09-11

2. Eruptive Keratoacanthomas After Nivolumab Treatment of Stage III Melanoma;Cutis;2023-05

3. A Case of Transient Eruptive Keratoacanthoma Associated With Nivolumab;Journal of the Dermatology Nurses' Association;2023-03

4. To treat or not to treat: PD-L1 inhibitor-induced keratoacanthoma and squamous cell carcinoma;Archives of Dermatological Research;2022-11-17

5. A novel report of nivolumab-induced transient and persistent acantholytic dermatosis associated with multiple cutaneous toxicities in a patient with metastatic melanoma;Acta Oncologica;2022-04-05